Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 265,692
  • Shares Outstanding, K 216,010
  • Annual Sales, $ 1,640 K
  • Annual Income, $ -16,440 K
  • 60-Month Beta -6.23
  • Price/Sales 170.12
  • Price/Cash Flow N/A
  • Price/Book 2.36
Trade IBIO with:

Options Overview

Details
  • Implied Volatility 126.20%
  • Historical Volatility 74.47%
  • IV Percentile 6%
  • IV Rank 9.43%
  • IV High 316.25% on 07/30/20
  • IV Low 106.42% on 04/12/21
  • Put/Call Vol Ratio 0.29
  • Today's Volume 2,785
  • Volume Avg (30-Day) 2,157
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 74,116
  • Open Int (30-Day) 61,583

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +1,665,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2200 +0.82%
on 04/16/21
1.7900 -31.28%
on 03/19/21
-0.5300 (-30.11%)
since 03/16/21
3-Month
1.2200 +0.82%
on 04/16/21
2.8300 -56.54%
on 02/10/21
-0.2400 (-16.33%)
since 01/15/21
52-Week
0.8555 +43.78%
on 04/21/20
7.4500 -83.49%
on 07/21/20
+0.2855 (+30.23%)
since 04/16/20

Most Recent Stories

More News
Human Papillomavirus Protein E7 Market Analysis, Recent Trends, Development, Top Company Players and Forecast 2020-2027 by Ameco Research

pune, India, Tue, 30 Mar 2021 02:52:43 / Comserve Inc. / -- Ameco Research indicates that the Global Human Papillomavirus Protein E7 Market is expected to surge at a steady rate in the coming years, as...

ADXS : 0.4690 (-9.67%)
IBIO : 1.2300 (-4.65%)
IMV.TO : 3.47 (-1.98%)
INO : 8.74 (-3.00%)
MFAC : 14.76 (-0.74%)
SELB : 3.87 (-1.53%)
iBio to Participate in the 33rd Annual Roth Conference

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced that it will participate in the 33 Annual Roth Conference, which...

IBIO : 1.2300 (-4.65%)
iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended December 31,...

IBIO : 1.2300 (-4.65%)
iBio, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 16, 2021 / iBio, Inc. (AMEX:IBIO) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 16, 2021 at 4:30 PM Eastern...

IBIO : 1.2300 (-4.65%)
iBio Appoints Robert M. Lutz as Chief Financial & Business Officer

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced the appointment of Robert M. Lutz as its Chief Financial & Business...

IBIO : 1.2300 (-4.65%)
iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, announced today that it will report its fiscal 2021 second quarter financial results...

IBIO : 1.2300 (-4.65%)
Thinking about buying stock in InspireMD, iBio, Nokia, Novan, or T2 Biosystems?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NSPR, IBIO, NOK, NOVN, and TTOO.

IBIO : 1.2300 (-4.65%)
NSPR : 0.4100 (-4.65%)
NOVN : 1.1000 (-7.56%)
TTOO : 1.3000 (unch)
NOK : 4.18 (+1.21%)
Thinking about buying stock in Apple, Digital Turbine, Draftkings, Canada Goose Holdings, or iBio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, APPS, DKNG, GOOS, and IBIO.

IBIO : 1.2300 (-4.65%)
AAPL : 134.16 (-0.25%)
DKNG : 57.98 (+0.87%)
APPS : 75.29 (-3.87%)
GOOS : 40.70 (+0.79%)
Immunotherapy Using Immune-Checkpoint Inhibitors (ICI) Modulators Are Revolutionizing Oncology Industry

, /PRNewswire/ -- Ovarian cancer is one of the most deadly gynecologic malignancy across the globe, but new treatments are gaining increased efficacy while displaying reduced toxicity. Clinical trials...

BIOV.CN : 0.360 (-5.26%)
LMNGF : 0.2963 (-1.23%)
VBLT : 1.6900 (-2.31%)
IBIO : 1.2300 (-4.65%)
INFI : 2.98 (-3.25%)
ADMP : 0.7290 (-1.17%)
Thinking about buying stock in iBio, Fluidigm Corp, Atossa Therapeutics, BioCryst Pharmaceuticals, or GameStop?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, FLDM, ATOS, BCRX, and GME.

IBIO : 1.2300 (-4.65%)
BCRX : 11.24 (-0.88%)
FLDM : 4.63 (-1.49%)
ATOS : 1.6300 (-5.78%)
GME : 154.69 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

3rd Resistance Point 1.3433
2nd Resistance Point 1.3167
1st Resistance Point 1.2733
Last Price 1.2300
1st Support Level 1.2033
2nd Support Level 1.1767
3rd Support Level 1.1333

See More

52-Week High 7.4500
Fibonacci 61.8% 4.9309
Fibonacci 50% 4.1528
Fibonacci 38.2% 3.3746
Last Price 1.2300
52-Week Low 0.8555

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar